Articles tagged with Drug Studies
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A new study suggests discontinuing statins in patients with life-limiting illness can improve quality of life without adverse health effects. The study found no significant differences in mortality between those who continued and discontinued statin therapy.
A new study evaluates currently available screening tools for senior cancer patients taking too many medications. It found that a more comprehensive assessment and monitoring plan is needed to improve treatment outcomes.
New approach aims to enhance neuroplastic processes, including angiogenesis, neurogenesis, oligodendrogenesis and axonal sprouting to improve neurological recovery. Early clinical trials are underway for innovative drugs such as Glibenclamide, Minocycline and Statins.
Researchers found that patients with narrower PICC lines and those taking aspirin and statins before PICC placement have a lower risk of DVT. Doctors should use PICCs only when necessary and monitor for clots, ensuring continued medication to prevent complications.
A study by Wake Forest Baptist Medical Center found that 27% of acne patients failed to get prescribed medications, with higher non-adherence rates for those taking multiple medications. Researchers suggest simplifying treatment regimens could reduce non-adherence.
Regular use of aspirin or NSAIDs reduces colorectal cancer risk, but rare genetic variants do not offer the same benefit to some individuals. The study found a 30% reduction in risk for most participants, but no protective effect for those with certain genetic variations.
Researchers at Henry Ford Health discovered that sildenafil improves neurological function even in middle-aged mice with long-term diabetic peripheral neuropathy. The study suggests new insights into underlying mechanisms and potential treatment for long-term diabetic neuropathy.
A new TB drug regimen, PaMZ, has shown promising results in a Phase 2b clinical trial, demonstrating the potential to treat both drug-sensitive and multidrug-resistant TB in four to six months. The regimen, comprising pretomanid and moxifloxacin, was found to be effective independent of HIV status.
A new study published in Medical Care found that specific health system factors, including prescriptions with a 90-day supply and lower copayments, nearly doubled the likelihood of patients adhering to prescribed heart and diabetes medications. The study examined nearly 130,000 Kaiser Permanente members with diabetes and aged 65 or older.
The study found bivalirudin to be associated with significantly lower rates of bleeding complications and death, but failed to meet its co-primary composite endpoints. The high prevalence of heart attacks in patients may have diluted the benefits reflected in the rates of death and bleeding.
A study published in the Journal of Patient Safety found that redesigned IV medication labels can significantly reduce the risk of medication errors in the operating room. The research used simulated surgical emergency scenarios and showed a higher correct selection rate with redesigned labels compared to standard labels.
A new study in baboons reveals that social relationships play a role in shaping an individual's gut microbial makeup. The researchers found that baboons who groomed each other more frequently shared more similar sets of gut microbes, suggesting that physical contact may be a key factor in allowing people to swap gut germs.
Patients over 80 with acute coronary syndromes who received invasive procedures had a 47% reduction in heart attacks, urgent revascularization, stroke, and death compared to conservative treatment. The study suggests that older patients may be denied necessary treatments due to their age.
A study of over 18,000 patients found that newer drug-coated stents have similar long-term rates of death as traditional bypass surgery. However, the stent group had slightly more heart attacks in the long term.
A new study finds that carotid baroreflex activation therapy (BAT) improves NYHA Class, quality of life scores and exercise capacity in symptomatic advanced heart failure patients receiving optimum drug therapy. BAT was safely implanted with few complications and no adverse effects.
A comprehensive study of over 95,000 patients found that glucose-lowering therapies prescribed to diabetes patients may pose an increased risk for the development of heart failure. The study showed a 14% overall increased risk of heart failure with intensive blood sugar-lowering drugs or strategies.
Patients with multivessel coronary artery disease receive better outcomes with coronary artery bypass grafting (CABG) than angioplasty and stent implantation, according to a study. This is in line with past studies that have shown CABG leads to better outcomes for patients with multiple narrowed arteries.
Patients taking evolocumab, a new class of cholesterol-lowering medications, were half as likely to die or experience a heart attack/stroke compared to those on standard care. The study found that patients treated with evolocumab had significantly lower rates of cardiovascular events and adverse effects.
The study found that adding ticagrelor to aspirin therapy after a heart attack significantly reduced the rate of subsequent death from cardiovascular causes, with benefits appearing for nearly three years. The trial recruited 21,162 patients and showed a 15% reduction in cardiovascular death with both ticagrelor doses.
Researchers discovered that Valacyclovir can reduce HIV-1 levels independently of herpes infection, promising new avenues for drug development. The study's findings suggest the potential for a broader range of HIV-fighting drugs and could inform the design of new agents based on Valacyclovir's molecular structure.
A comprehensive review of 39 clinical trials found no evidence of increased risk of suicidal behavior, depression, or death in Varenicline users compared to placebo groups. The study also showed a 25% reduction in the risk of anxiety, likely attributed to the positive impact of quitting smoking on mental health.
Researchers examined the effects of Amitriptyline, Gabapentin, and Carbamazepine on human skin keratinocyte and oral keratinocyte cells. The study found that lower concentrations of Amitriptyline were more cytotoxic to HaCat cells, while Gabapentin and Carbamazepine had less toxic effects.
Duke Medicine researchers found that only 13.4% of clinical trials reported findings within the required one-year window, with industry-sponsored trials reporting at 17%, while academic/non-NIH-funded trials reported at just 5.7%. The lack of transparency hampers progress and violates obligations to patients.
A new natural treatment for Alzheimer's disease, withanamides, is being developed by Michigan State University. The compound has shown to protect brain cells from damage caused by the rogue protein BAP, which is a common factor in Alzheimer's progression.
A study led by Drs. Kelleher and Shen discovered that presenilin-1 mutations decrease gamma-secretase activity, leading to age-dependent death of neurons and neurodegeneration. The findings may transform the way scientists design drugs for inherited Alzheimer's disease.
Researchers found a conclusive link between genetic variants and increased bleeding risk with warfarin treatment. Patients with specific genetic differences benefit from alternative anticoagulants like edoxaban, offering improved safety and efficacy.
Scientists at Imperial College London developed a test using human stem cells to predict severe immune reactions to new drugs. The test recreates the unique conditions found in blood vessels, making it a more reliable method than current tests.
A new study by researchers from the Richard L. Roudebush VA Medical Center, the Regenstrief Institute, and Indiana University School of Medicine reports that a stepped-care strategy improved function and decreased pain severity in veterans with chronic musculoskeletal pain, producing at least a 30 percent improvement in pain-related di...
A McGill University study reveals that only 37% of registered drug trials in cancer, cardiovascular, and neurological diseases were published between 2005 and 2009. The findings highlight the importance of sharing information from stalled drug trials to improve care, protect patients, and discover better drugs.
A new experimental drug, GC-1, has been found to convert 'bad' white fat into 'good' brown-like fat, leading to weight loss and improved insulin sensitivity in mice. Researchers believe this conversion may help treat obesity and metabolic disease.
A phase 3 clinical trial found that abaloparatide reduces the rate of new spinal fractures by 86 percent and also significantly lowers the fracture rate at other parts of the body. The treatment also delays the time to the first nonvertebral fracture and increases bone mineral density.
A systematic review of studies on racial/ethnic variations in overuse of health care found that a substantial proportion (43%) suggests white patients receive excessive testing and treatment. Researchers emphasize the need for carefully designed interventions to minimize unintended consequences.
A recent study found that the apixaban-amiodarone combination significantly decreased stroke risk for patients with AFib who require both heart rhythm regulation and blood thinning medication. This alternative to warfarin offers a better option for managing high-risk atrial fibrillation.
A meta-analysis of 29 studies involving over 120,000 men found no connection between testosterone therapy and increased risk of heart problems. An observational study from Wisconsin also showed low cardiovascular event rates in both treated and untreated groups.
The GeneSight test combines multiple gene variations to predict patient responses to medications, improving treatment outcomes and healthcare resource utilization. The study found that patients on red category medications showed significantly less improvement in depressive symptoms.
Patients taking digoxin for atrial fibrillation face a 27% increased risk of dying compared to those not on the medication. The analysis of 19 studies involving over 500,000 patients also found that those with kidney failure are at an especially high risk.
Research suggests that early life stress can lead to an excess release of serotonin, resulting in a deficit. This could explain why many people with depression and anxiety disorders don't respond well to SSRIs, which aim to increase serotonin levels.
The Journal of Vascular and Interventional Radiology presented awards for papers on stent patency and inhibiting tumor growth at the Society of Interventional Radiology's Annual Scientific Meeting. These awards recognized advancements in chemotherapy and radiation, leading to improved patient outcomes.
Researchers found that company dossiers and dossier assessments contain significantly more information than conventional documents on clinical studies, especially regarding patient-relevant outcomes. This suggests that early benefit assessment may be a model for increased transparency in other areas.
A Group Health study of over 3,000 patients found that anticholinergic medications increase the risk of pneumonia in older adults. The study suggests that clinicians should review medications regularly to identify potential risks and explore alternative treatments.
A study published in JAMA Internal Medicine found that nut and peanut consumption was associated with a reduced risk of total mortality and cardiovascular disease death across different ethnic groups. The study suggested that peanuts, due to their affordability, may be a cost-effective measure to improve cardiovascular health.
Researchers found a consistent dose-response relationship between paracetamol and adverse events, including mortality, cardiovascular, gastrointestinal, and renal problems. This suggests that clinicians should reevaluate the drug's effectiveness and tolerability for certain conditions, particularly when analgesic benefit is uncertain.
A new study suggests that taking popular anti-smoking medication for several weeks before quitting may make it easier to quit and stay quit. The research found that extending the use of bupropion prior to quitting reduced smoking during that period without increasing craving or withdrawal.
The NIH/National Institute of Allergy and Infectious Diseases has launched a clinical trial to test the safety and efficacy of ZMapp, an experimental Ebola treatment. The study will enroll adults and children with known Ebola infection and compare the treatment to standard care.
A large retrospective study of 885 patients with soft-tissue sarcoma found that YONDELIS treatment was effective, with median progression-free survival and overall survival of 4.4 and 12.2 months, respectively. Early administration as second-line therapy may optimize efficacy.
Researchers found that blocking interleukin-1, a master regulator of inflammation, increased the risk of coronary heart disease and abdominal aortic aneurysm. In contrast, naturally occurring interleukin-1 inhibition decreased the risk of rheumatoid arthritis.
A study published in Science Translational Medicine shows that treating cats with Niemann Pick Type C with cyclodextrin significantly improved their neurological symptoms. The treatment halted disease progression and allowed the cats to live past three years of age, making it a promising potential therapy for human patients.
A recent study published in the American Journal of Public Health found that one in four prison inmates have a diagnosed mental health condition, yet few receive treatment. The study highlights the need for prisons to prioritize validated screening procedures and treatment for mental health disorders.
A new study in JAMA found that patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) along with anticoagulant medications after a heart attack are at higher risk for bleeding and cardiovascular events. The research suggests that there is no safe window for concomitant NSAID use, even short-term treatment.
The JIKI clinical trial found encouraging signs of efficacy for favipiravir in individuals with high or moderate viral replication and less severe visceral lesions. In contrast, patients with very high viral loads and serious visceral involvement showed no efficacy from the treatment. These findings have implications for Ebola virus di...
Researchers at UC San Diego found that LTB4 promotes insulin resistance in obese mice, but blocking the LTB4 receptor improves insulin sensitivity. Genetic deletion or drug inhibition of the receptor prevents and reverses type 2 diabetes in this model.
A new study found that intensive lifestyle intervention or medication can significantly reduce the risk of developing Type 2 diabetes in women who had gestational diabetes. Women with a history of gestational diabetes were less likely to develop diabetes when assigned to take metformin or undergo intensive lifestyle intervention.
A phase three trial found that using sunitinib or sorafenib after surgery did not reduce recurrence in high-risk renal cell carcinoma patients, compared to standard care. The study, E2805, involved 1943 patients and demonstrated no significant differences in disease-free survival or overall survival between treatment groups.
The Alfred P. Sloan Foundation has selected 126 outstanding early-career scientists as recipients of the 2015 Sloan Research Fellowships. These fellowships honor innovative research in eight fields, including chemistry, computer science, economics, and physics.
A new investigational drug, reslizumab, has been shown to reduce asthma attacks in patients who have difficulty controlling the disorder with standard medications. The study found that patients treated with reslizumab were at least 50% less likely to experience severe asthma exacerbations.
Patients with locally advanced kidney cancer did not experience improved outcomes from adjuvant treatment with sorafenib or sunitinib. The average disease recurrence period was similar between those receiving the drugs and those on placebo, suggesting that these treatments may not be beneficial for this patient group.
A University of Iowa expert will testify before the Presidential Task Force on 21st century policing, sharing her research on improving police officer health and wellness. Her pilot intervention program has shown promise in reducing stress-related disability, improving officer retention, and increasing job satisfaction.
USF scientists found that statins produce a significant reduction in cholesterol levels but have failed to substantially improve cardiovascular outcomes. The researchers argue that advocates for statins have used statistical deception to inflate their effectiveness and downplay adverse effects.
The phase II study results indicate that palbociclib can extend disease control and produce tumor shrinkage in ER+ breast cancer patients. Researchers observed significantly longer progression-free survival in hormone receptor-positive patients compared to those with HR-negative breast cancer.
Researchers have identified a new gene, TBK1, associated with sporadic ALS, highlighting the importance of inflammation and autophagy pathways. The study also found that OPTN may be a major player in the disease, interacting physically and functionally with TBK1.